Korean J Hematol.  2000 May;35(2):117-125.

The Frequency and Clinical Significance of Multidrug Resistance-1 (MDR-1) Gene Expression in Acute Myeloid Leukemia

Affiliations
  • 1Department of Internal Medicine, Kyungpook National University, School of Medicine, Taegu, Korea.
  • 2Department of Clinical Pathology, Kyungpook National University, School of Medicine, Taegu, Korea.
  • 3Department of Cancer Research Institute, Kyungpook National University, School of Medicine, Taegu, Korea.

Abstract

BACKGROUND: The expression of the multidrug resistance-1 (MDR-1) gene which encodes p-glycoprotein, is recognized as a biological mechanism possibly contributing to treatment failure in patients with acute myeloid leukemia (AML). Recent studies indicate its association with poor risk factors such as cytogenetic pattern and surface phenotype of blasts. We analyzed the role of MDR-1 gene expression in 36 chemo-naive AML patients.
METHODS
In 36 patients, clinical data were reviewed and compared to MDR-1 gene expression, immunophenotyping results on CD7 & CD34, cytogenetic pattern and other suggestive prognostic factors.
RESULTS
Median follow-up period was 150 days. The MDR-1 gene expression was observed in 19 out of 36 patients (52.8%). Significant correlation between MDR-1 gene and CD7 & CD34 expression was found. Sixteen out of 17 (94.1%) MDR-1 negative patients harbored favorable cytogenetic patterns, where as 11 out of 19 (57.9%) MDR-1 positive patients had favorable cytogenetic patterns. MDR-1 gene expression was not correlated to disease free survival (DFS), nor overall survival (OS) statistically although it has shown significant correlation to complete remission (CR) rate (P =0.001).
CONCLUSION
We found that lack of MDR-1 gene expression was exclusively associated to favorable cytogenetic patterns in our study. In order to clarify the relationship between the role of MDR-1 gene and clinical outcome or other prognostic features, including cytogenetic pattern, further larger studies would be necessary.

Keyword

Multidrug resistance (MDR-1) gene; Acute myeloid leukemia; CD marker; Cytogenetic pattern

MeSH Terms

Cytogenetics
Disease-Free Survival
Follow-Up Studies
Gene Expression*
Humans
Immunophenotyping
Leukemia, Myeloid, Acute*
P-Glycoprotein
Phenotype
Risk Factors
Treatment Failure
P-Glycoprotein
Full Text Links
  • KJH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr